Biomedical literature, made navigable
Discover articles through diseases, drugs, treatments, interventions, clinical instruments, institutions and funders extracted from the BMJ open corpus.
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsChoose an entity to see the articles in which it was identified.
…tment of patients with certain malignancies, clinical trials in prostate cancer have shown ICIs to have very limited efficacy. To understand th…
…Acknowledgements We thank Nadim Ajami and Jennifer Wargo of the MD Anderson Cancer Center for their continued support of the KAN-001 program.Ethics Appro…
…tial treatment strategy for patients with STK11-mutated tumors. TNG260 in combination with pembrolizumab is currently being evaluated …
…overcoming immune resistance in both small cell lung cancer and non-small cell lung cancer, its application in the immunotherapy of ESCC patients remains …
…2 exposure, indicating robust immune activation associated with WTX-124. Ex vivo multiplex IF analysis of tumor tissues revealed an ele…
… may serve as a novel immunoregulatory marker in the irradiated glioblastoma tumor microenvironment. Ongoing studies will determine whether …
…st solid tumors.References Li D, Xie K, Wolff R, Abbruzzese JL. Pancreatic cancer . Lancet. 2004;363:1049–57.Siegel RL, Kratzer TB, Giaquinto AN.…
… studies that demonstrated an enhanced anti-tumor response with Vidutolimod treatment, especially in combination with anti-PD-1 therapy.Eth…
…Background Prostate cancer is the most commonly diagnosed cancer in men in the USA after s…
…, liver, spleen or brain tissues at the 3mg/kg dose.Conclusions PB-vcMMAE-5 demonstrated potent in vitro and in vivo anti-tumor activity an…
…Background Oesophageal cancer (EC) is a common cause of cancer mortality. Evidence on the bur…
…mprehensive Specialised Hospital.Participants 420 patients with type 2 diabetes mellitus with poor glycaemic control after the index date were included …